Background. Natural killer (NK) cells and plasmacytoid and myeloid dendritic cells (DCs) are depleted, and their function impaired, in advanced adult human immunodeficiency virus (HIV)-1 infection. Studies in perinatally infected children are lacking.
+ /56
+ /16 + ) NK cell subset and decreased interferona secretion by plasmacytoid DCs. Despite similar viral loads, percentages of myeloid and plasmacytoid DCs and mature NK cells were significantly lower in viremic children with a history of decreasing CD4 + cell percentages, compared with children with stable CD4 + cell counts.
Conclusions. Children achieve partial reconstitution of myeloid and plasmacytoid DCs and NK cells during viral suppression; irrespective of viral load, a clinical history of decreasing CD4
+ cell percentage is associated with greater depletion of these subsets. We hypothesize that the evaluation of selected innate-immunity effector cells may serve as a marker of CD4 + cell loss in pediatric HIV-1 infection.
Recent reports on HIV-1 immunopathogenesis have increasingly focused on the role of the innate immune system, particularly numbers and function of dendritic cells (DCs) and NK cells [1] [2] [3] . DCs initiate T and B cell responses [4] , produce interleukin (IL)-12 and interferon (IFN)-a, and participate in the innate immune response against pathogens [5, 6] . Two distinct circulating subpopulations of DCs are recognized in humans-myeloid and plasmacytoid [6] -and both are depleted in adult patients with advanced HIV-1 disease [7] [8] [9] [10] , but only myeloid DCs are fully recovered after successful antiretroviral therapy (ART). Together with CD4 + cell counts, decreased IFN-a production and numbers of plasmacytoid DCs [7, 8, 11, 12] are independent predictors of clinical progression and the onset of opportunistic infections [13] . An inverse association between plasmacytoid DC-mediated IFN-a secretion and opportunistic infections indicate a potential role for IFN-a-mediated activation of NK-mediated responses in asymptomatic patients [13] [14] [15] . NK cells lyse HIV-1-infected cells [16, 17] and contribute to the control of viral infections, as has been established in murine models [18] . Past work has demonstrated the ability of Lin1 Ϫ /HLA-DR + DCs to activate NK cells to lyse target cells [19] . Furthermore, IFN-a produced by HLA-DR + cells has been shown to be necessary for NK cell-mediated lysis of virally infected cells [20, 21] . Most studies, including ours [22] , have shown a decrease in NK cytotoxicity in viremic HIV-positive adult patients in association with the depletion of mature cytotoxic NK cell subsets [23] [24] [25] , identified on the basis of coexpression of CD161 with CD56 and/or CD16 cells [22, 26] . A partial recovery of functionally mature NK sub-sets is observed after ART-mediated viral suppression in adults [22, 27] , whereas, in children, aggressive combination ART results in CD4 + cell reconstitution [28] [29] [30] , but little is known about innate immune reconstitution. CD4 + cell counts and HIV RNA load predict the risk of disease progression and opportunistic infections in adults, independently [31] [32] [33] or in combination [34, 35] . In children, CD4 + cell percentage is considered to be a better predictor of clinical progression than serum HIV RNA load [36] , with a sharp increase in the risk for AIDS indicated by CD4 + cell percentages of !15%, which highlights a need for additional parameters predictive of future CD4 + cell loss. We established, in earlier studies [37] , that children with stable CD4 + cell counts and partial viral suppression (viral load !50,000 copies/mL) while receiving ART had higher levels of lymphoproliferative responses to HIV-1 antigens, reduced expression of activation markers (CD38 and HLA-DR), and higher percentages of CD8 + / CD28 + cells, compared with viremic children who had shown a 115% decline in CD4 + cell percentages during the preceding year. We report the results of a cross-sectional study of 40 HIV-1-infected children that identified pediatric-specific outcomes of innate immune reconstitution after successful ART-mediated viral suppression and identified novel innate immune parameters that are affected to a greater extent in HIV-1-positive viremic children who had a history of decreasing CD4 + cell percentage (change in CD4 + cell percentage of 115% during the preceding year), compared with children who had stable CD4 + cell counts.
SUBJECTS, MATERIALS, AND METHODS

Patient population.
Forty children with HIV-1 infection and 11 age-and sex-matched, HIV-negative control children were recruited at the Children's Hospital of Philadelphia (CHOP / stimulation in 1 mL of RPMI 1640 with medium alone (control), cell-free viral UV cross-linked supernatant (5HA Influenza-PR8; 10 hemagglutinin units/mL), or CpG-2216 (10 mg/ mL; Integrated DNA Technologies). Cell-free supernatants were harvested and tested in duplicate for IFN-a by use of a commercial ELISA, according to the manufacturer's instructions (Endogen). Absorbance was measured on an automatic plate reader. Sensitivity of the assays was ∼10 pg/mL. Recombinant cytokine standards were used in ELISA assays. "Per cell" IFN- + cell percentage. Correlations between variables were evaluated by use of the Spearman rank correlation test. For all tests, 2-sided was considered to be significant, unless P ! .05 otherwise stated. All tests were performed by use of the statistical software Analyse-it or JMP (SAS Institute). In all graphics, brackets indicate significant differences between groups.
RESULTS
Patient cohort.
Our cohort was composed of 40 children: 18 girls and 22 boys; 29 were black, 7 white, and 4 Hispanic. All children had been previously treated with combination ART, and 37 children were undergoing treatment at the time of analysis. The mean age of our HIV-positive patient group was 11.1 years; this was matched to the control uninfected group. In the HIVpositive group, 19 children had CD4 + cell percentages of 130%, 15 had percentages of 20%-30%, and 5 had percentages of !20%. Of the 40 HIV-infected children, 22 had undetectable serum HIV RNA loads (!400 copies/mL), whereas the median viral load of viremic children was 31,000 copies/mL (IQR, 116,550 copies/ mL cell percentage of all viremic children was 22%, whereas that of fully suppressed children was 34%. As expected, in viremic children, the CD4 + cell percentage was inversely correlated to the viremia level ( figure 1A) . However, HIV RNA loads (figure 1B) did not segregate children with different histories for change in CD4 + cell count during the preceding year; no significant difference in HIV load was observed between viremic children who had a history of declining (median HIV RNA load, 27,500 copies/ mL [IQR, 11,562 copies/mL]) or stable CD4 + cell counts (median HIV RNA load, 12,000 copies/mL [IQR, 222,098 copies/mL]).
Selective depletion of NK cell subsets in viremic HIV-infected children. To determine whether HIV infection resulted in the depletion of any NK cell subset, as has been observed in adults [22] , we studied the expression of CD161, CD56, and CD16 on CD3 Ϫ lymphocytes in viremic and ART-suppressed (!50 copies/ mL) children (2 children with missing viral loads were excluded from this analysis creasing CD4 + cell percentage) is associated with plasmacytoid DC depletion. Surprisingly, no difference in plasmacytoid DC percentage was observed between HIV-positive suppressed children and their HIV-negative counterparts, which suggests that, unlike adults [9] , HIV-infected children may recover the plasmacytoid DC subset after viral suppression. When the history of CD4 + cell percentage retention was taken into consideration ( figure 3C) for P ! .05 both comparisons). Further analysis of CD86 mean fluorescence intensity (MFI) on plasmacytoid DCs as a molecule highly expressed on terminally differentiated DCs or of CD95 showed no significant difference in expression among HIVnegative, HIV-positive suppressed, and viremic children, irrespective of the decline in CD4 + cell percentage ( figure 3D ). To monitor plasmacytoid DC function, the secretion of IFNa was assessed on stimulation of isolated PBMCs with 5HA influenza-PR8 or the Toll-like receptor (TLR)-9 ligand CpG-2216. Both stimuli are considered to be relatively plasmacytoid DC specific, given that only plasmacytoid DCs and B lymphocytes express relevant amounts of TLR-9 [38] and that type A CpGs (such as 2216) are known to preferentially activate plasmacytoid DCs [39, 40] . With both stimuli, we observed a significantly lower ( ) level of IFN-a production in all HIV-P ! .05 positive children, with median values of 177 pg/mL (IQR, 187 pg/mL) and 235 pg/mL (IQR, 229 pg/mL) for 5HA influenza-PR8-induced IFN-a and of 69 pg/mL (IQR, 332 pg/mL) and 135 pg/mL (IQR, 190 pg/mL) for CpG-2216, compared with levels in control children (influenza, 456 pg/mL [IQR, 186 pg/ mL]; CpG-2216, 298 pg/mL [IQR, 162 pg/mL]). No significant differences were observed between the HIV-infected suppressed and viremic subgroups when we analyzed secretion levels. In keeping with this observation, no correlation was observed between IFN-a production and CD4 + cell percentage, serum HIV RNA load, or a history of declining/stable CD4 + cell count in viremic children (figure 4), which indicates a sustained functional impairment, despite changes in the percentage of circulating plasmacytoid DCs.
To assess whether the observed impairment of IFN-a production was due exclusively to the loss of plasmacytoid DCs in PBMCs, we estimated the amount of IFN-a produced by each plasmacytoid DC on stimulation with the TLR-9-specific CpG-2216, as described in Subjects, Materials, and Methods. Whereas, in control children, each plasmacytoid DC produced a median 0.27 pg of IFN-a (IQR, 0.13 pg), this amount was significantly lower in HIV-infected children (median, 0.06 pg [IQR, 0.37 pg]; 1-sided ). No significant differences were P ! .05 noted between HIV-infected viremic and suppressed children. A similar trend was also observed when PR-8 stimulation was used, which supports the hypothesis of a functional cellular impairment in plasmacytoid DC secretion.
Depletion of myeloid DCs in children with advanced HIV infection. We analyzed the percentage of Lin-1 Ϫ /HLA-DR + / CD11c + myeloid DCs, to determine how HIV infection affects this DC subset in HIV-infected viremic and suppressed children. Contrary to previous observations by our group and others in adults [7, 9, 10, 41] figure 5A ) children, which supports the hypothesis that disease progression is associated with loss of myeloid DCs in children. As was observed in plasmacytoid DC subsets, no significant difference in the expression (according to MFI) of CD86 and CD95 (figure 5B) was observed between groups.
DISCUSSION
We assessed innate immunity correlates of viral control and sustained CD4 + cell percentage in HIV-infected, ART-treated children. Our observations suggest that, contrary to adults, children fully recover plasmacytoid DC percentages, as well as those of myeloid DCs and most NK cell subsets, on viral suppression. This recovery appears to be functionally incomplete, as was demonstrated by the failure to recover mature CD161 + CD56 + CD16 + NK subsets [26, 42, 43] and IFN-a secretion by plasmacytoid DC subsets. We also identify significant changes in percentage of circulating NK and plasmacytoid and myeloid DC subsets that identify viremic children with a history of declining versus stable CD4 + cell percentage during the previous year of clinical follow-up.
In adults, we and others [22, 23, 25, [44] [45] [46] [47] [48] [49] [50] [51] have demonstrated that numbers of NK cells are reduced during the course of HIV infection, with an inverse correlation with the stage of disease. Some NK cell functions (e.g., cytotoxicity) are reconstituted on viral suppression, whereas others remain impaired (e.g., cytokine-induced IFN-g production) [22] . Because, in adults, phenotypically mature NK cells-characterized by the coexpression of CD161, CD56, and/or CD16-account for IFNg production and cytotoxicity mediated by either granule release or Fas/Fas-ligand interaction [26, 42] , it is reasonable to speculate that their depletion may be associated with the reduction in "natural" and antibody-dependent cytotoxic activity + myeloid DCs, studied on whole blood, as described in figure 2 . B, Whole-blood mean fluorescence intensity (MFI) of CD86 or CD95, assessed in separate staining on gated Lin1
Ϫ /HLA-DR + /CD11c + cells, as described in figure 2. Group assignment within each panel, box graph distributions and line brackets are as described in figure 2.
reported in viremic HIV-infected children [51] . Although, globally, the NK subsets expressing CD56 are similar to those in HIV-infected suppressed children, the persistent decrease in the major mature subset of CD161 + CD56 + CD16 + promotes the hypothesis that immune reconstitution in infected children might be impaired with regard to NK function. Functional longitudinal studies will be necessary to establish whether ART-mediated viral suppression results in full reconstitution of the functions of the NK cell subset (e.g., IFN-g production on IL-2/IL-12 stimulation).
In contrast to that in adult subjects [9, 10, 12] , the plasmacytoid DC percentage was similar in control and HIV-infected suppressed children. However, similar to findings in infected adults [9, 10, 12] , a significantly lower percentage of plasmacytoid DCs was observed in viremic children, compared with that in HIV-infected suppressed children, and a sustained impairment in IFN-a secretion was present irrespective of viral suppression. Potential factors that may influence the increase of a functionally impaired plasmacytoid DC subset on viral suppression in children include an increased plasticity of the innate immune system and the anticipated longer time on therapy in our cohort-most children had been treated since infancy. Altogether, even though the reduction of PDC percentage in viremic children might contribute to the impairment of IFNa production, the observation of a reduced "per cell" production of IFN-a by plasmacytoid DCs on stimulation with TLR-9-specific CpG-2216 in all HIV-infected children, independent of viremia, supports a persistent functional impairment at the cellular level irrespective of viral suppression.
It is important to consider that results from our ongoing and published longitudinal studies in infected adults starting suppressive ART [52] indicate that, although normal (uninfected) levels of IFN-a secretion and plasmacytoid DC percentages are not recovered, an increase from pretreatment levels is observed after viral suppression. Because adults and children have differences in the plasticity of their immune systems, longitudinal studies in pediatric cohorts will be required to determine whether similar changes are observed in newly treated children.
In agreement with studies conducted in adults [7] [8] [9] [10] , myeloid DC percentage was reduced in HIV-infected children with advanced disease (i.e., a history of declining CD4 + cell percentage). However, similar percentages of Lin1 + cell counts, independent of viremia, which indicates that either complete control of viral load resulted in myeloid DC recovery over time in this subgroup or that therapy was started at a time when this subset was not depleted.
It is important to note that children in our cohort were treated early in life and are generally older (mean age, 11.1 years) and more heavily ART-experienced than those in previous studies. Data on the exact duration of ART therapy (and possible interruptions) were not available for many of our subjects, making it difficult to interpret whether the amount of confirmed time on ART was a direct correlate to the levels of innate immunity effectors and/or history of CD4 + cell percentages. Furthermore, because most children in the cohort started ART shortly after birth, we interpret that their age is an indicator of the time receiving ART. However, our data do not rule out that the observed outcomes may depend, at least in part, on the clinical efficacy of ART in suppressing viral replication, relative to changes in CD4 + cell percentage during the course of child development. Interestingly, stratification of our HIV-infected children on the basis of US Centers for Disease Control and Prevention class did not segregate children with decreasing or stable CD4
+ cell percentages and did not correspond to differential frequency or functionality of NK cells or DCs (data not shown), which suggests that prior "worse ever" status is not predictive of the innate immunity-related outcomes that we studied or of the patient's ability to sustain their CD4 + cell percentage. Finally, the presence of children with low viral loads (subjects 3 and 10) in the viremic cohort did not bias our results-testing repeated after excluding these samples resulted in the same trends as in the whole cohort (data not shown).
Although the association of a history of CD4 + cell retention in viremic children with increased retention of innate subsets of plasmacytoid and myeloid DCs and NK subsets suggests a role for immune function or "innate fitness" as a factor associated with a stable CD4 + cell percentage, the cross-sectional nature of the study does not allow us to determine whether the decrease in innate function is a cause or a consequence of the decrease in CD4 + count. This remains to be established in future longitudinal studies.
In conclusion, our results constitute, to our knowledge, the first comprehensive assessment of innate immunity cellular effectors in children, and they indicate that (1) selected innate immune cells and function are depleted in HIV-infected suppressed children; (2) differences may exist between infected adults and children in innate immune reconstitution after ART; and (3) innate immune effector cell (NK cells and plasmacytoid and myeloid DCs) percentage and function are impaired in viremic children, irrespective of the presence of partially suppressive ART, particularly in those with a history of decreasing CD4 + percentages.
